Danaher outlines 3%-6% core revenue growth and $8.35-$8.50 EPS guidance for 2026 amid bioprocessing strength
Earnings Call Insights: Danaher Corporation (DHR) Q4 2025 Rainer Blair, President, CEO & Director, reported "a strong...
Tag: DHR
Danaher drops after in-line earnings outlook
Danaher (DHR) shares slipped ~5% in the premarket on Wednesday after the life sciences company failed to impress Wall Street...
Danaher Non-GAAP EPS of $2.23 beats by $0.04, revenue of $6.84B beats by $30M
Danaher press release (DHR): Q4 Non-GAAP EPS of $2.23 beats by $0.04. Revenue of $6.84B (+5.2% Y/Y) beats by $30M....
Danaher Q4 2025 Earnings Preview
Danaher (DHR) is scheduled to announce Q4 earnings results on Wednesday, January 28th, before market open. The consensus...
Agilent, Danaher could be potential buyers of Qiagen – analyst
Agilent Technologies (A) and Danaher (DHR) screen as potential buyers of Qiagen (QGEN) after a report that the European...
Federal appeals court rejects NIH research funding cuts
A U.S. appeals court has ruled against the Trump administration’s moves to implement drastic cuts to federal grant funding...
Danaher declares $0.32 dividend
Danaher (DHR) declared $0.32/share quarterly dividend, in line with previous. Forward yield 0.57% Payable Jan. 30; for...
Agilent, Danaher, Thermo Fisher new buys at Goldman Sachs
Goldman Sachs has initiated coverage of large-cap life sciences tools companies, naming Agilent (A), Danaher (DHR), and...
Danaher outlines 2026 growth target of 3%-6% amid cost actions and bioprocessing momentum
Earnings Call Insights: Danaher Corporation (DHR) Q3 2025 CEO Rainer Blair emphasized strong third quarter results, driven...